Viral Inactivation Market Report 2026
Viral Inactivation Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Viral Inactivation Market Report 2026

Global Outlook – By Product (Kits And Reagents, Systems, Services), By Method (Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods), By Application (Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Viral Inactivation Market Overview

• Viral Inactivation market size has reached to $5.47 billion in 2025

• Expected to grow to $9.17 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Rising Prevalence Of Infectious Diseases To Drive Market Growth

• Market Trend: Advancing Safety And Efficiency With Next-Generation Viral-Clearance Solutions

North America was the largest region in 2025 and Asia-pacific is the fastest growing region.

What Is Covered Under Viral Inactivation Market?

Viral inactivation refers to the process of inactivation of viral contamination by exposing the bioprocess fluid to environments that denature the viral protein yet retain the active ingredient of the product. Viral inactivation is most commonly used in blood plasma processing and monoclonal antibody processing.

The main products of viral inactivation are kits and reagents, systems, and services. The solvent detergent method refers to the process that involves damage to the lipid membrane of encapsulated viruses and causes their inactivation. The solvent detergent method is used in plasma to safely render all lipid-enveloped viruses. The viral inactivation typically has solvent detergent method, pH adjustment method, pasteurization, and other methods that are applied in vaccines and therapeutics, tissues and tissue products, blood and blood products, and other applications. The end-users include pharmaceutical and biotechnology companies, contract research organizations, blood banks, hospitals, academic research institutes, and other end users.

Viral Inactivation Market Global Report 2026 Market Report bar graph

What Is The Viral Inactivation Market Size and Share 2026?

The viral inactivation market size has grown rapidly in recent years. It will grow from $5.47 billion in 2025 to $6.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing production of plasma-derived products, expansion of monoclonal antibody manufacturing, rising regulatory emphasis on viral safety, growth of biopharmaceutical manufacturing capacity, wider adoption of solvent detergent methods.

What Is The Viral Inactivation Market Growth Forecast?

The viral inactivation market size is expected to see rapid growth in the next few years. It will grow to $9.17 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for biologics and biosimilars, rising investments in advanced bioprocessing facilities, growing focus on continuous manufacturing, increasing adoption of automated quality control systems, expansion of vaccine production pipelines. Major trends in the forecast period include increasing adoption of automated viral inactivation systems, rising demand for validated virus safety processes, growing use of continuous flow inactivation methods, expansion of single-use bioprocessing solutions, enhanced focus on process reproducibility and compliance.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Viral Inactivation Market Segmentation

1) By Product: Kits And Reagents, Systems, Services

2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:

1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

3) By Services: Viral Testing Services, Validation Services, Consulting Services

What Is The Driver Of The Viral Inactivation Market?

Growing instances of various infectious diseases are expected to propel the growth of the viral inactivation market, going forward. Infectious diseases refer to the conditions that transmit from one individual to another, via polluted foods and beverages, and through pathogens such as viruses, bacteria, fungi, and parasites. Viral inactivation is widely applicable in human disease-control programs to inactivate viruses using physical and chemical disinfectants to prevent the spread of contagious viral infections, resulting in the growth of the viral inactivation market. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency of the United States, the number of cases of tuberculosis increased from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. The rate also increased from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Therefore, the growing instances of various infectious diseases are driving the growth of the viral inactivation industry.

Key Players In The Global Viral Inactivation Market

Major companies operating in the viral inactivation market are Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG

Global Viral Inactivation Market Trends and Insights

Major companies operating in the viral inactivation market are focusing on incorporating advanced viral-clearance technologies to enhance biologic safety, regulatory compliance, and process efficiency. These technologies, which inactivate viruses through chemical, physical, or filtration-based mechanisms, enable capabilities such as log-reduction validation, regulatory-compliant viral safety assurance, and faster decision-making in biologics development. For instance, in May 2025, Northway Biotech, a Lithuania-based contract development and manufacturing organization (CDMO), launched Full-Service Viral Clearance Studies (VCS), an advanced viral-clearance solution designed to accelerate safety validation for protein biologics and gene therapies, featuring multiple identical BSL-2 laboratories for high-throughput workflows, BSL-3 testing capabilities, and delivery of full regulatory-compliant viral clearance results in under 10 weeks, significantly faster than industry norms. This offering improves development speed, cost control, and regulatory readiness for biopharma clients.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Viral Inactivation Market?

In November 2025, Croda International Plc, a UK-based specialty-ingredients company, entered into a strategic partnership with Amino GmbH. With this collaboration, Croda and Amino aim to expand global access to high-purity amino acids for pharmaceutical formulation and biomanufacturing, enabling faster therapy development, consistent regulatory-grade raw-material availability, improved sustainability, and enhanced manufacturing efficiency. Amino GmbH is a Germany-based manufacturer of pharmaceutical-grade amino acids and brings advanced precision-manufacturing expertise tailored for pharma and nutritional applications.

Regional Outlook

North America was the largest region in the viral inactivation market in 2025. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Inactivation Market?

The viral inactivation market includes revenues earned by chemical viral inactivation and radiation viral inactivation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viral Inactivation Market Report 2026?

The viral inactivation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral inactivation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Viral Inactivation Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.05 billion
Revenue Forecast In 2035 $9.17 billion
Growth Rate CAGR of 10.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Method, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Viral Inactivation Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Viral Inactivation Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Viral Inactivation Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Viral Inactivation Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Automated Viral Inactivation Systems

4.2.2 Rising Demand For Validated Virus Safety Processes

4.2.3 Growing Use Of Continuous Flow Inactivation Methods

4.2.4 Expansion Of Single-Use Bioprocessing Solutions

4.2.5 Enhanced Focus On Process Reproducibility And Compliance

5. Viral Inactivation Market Analysis Of End Use Industries

5.1 Pharmaceutical And Biotechnology Companies

5.2 Contract Research Organizations

5.3 Blood Banks

5.4 Hospitals

5.5 Academic Research Institutes

6. Viral Inactivation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viral Inactivation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Viral Inactivation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Viral Inactivation Market Size, Comparisons And Growth Rate Analysis

7.3. Global Viral Inactivation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Viral Inactivation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viral Inactivation Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viral Inactivation Market Segmentation

9.1. Global Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Kits And Reagents, Systems, Services

9.2. Global Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

9.3. Global Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

9.4. Global Viral Inactivation Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

9.5. Global Viral Inactivation Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

9.6. Global Viral Inactivation Market, Sub-Segmentation Of Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

9.7. Global Viral Inactivation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Testing Services, Validation Services, Consulting Services

10. Viral Inactivation Market Regional And Country Analysis

10.1. Global Viral Inactivation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Viral Inactivation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viral Inactivation Market

11.1. Asia-Pacific Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viral Inactivation Market

12.1. China Viral Inactivation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viral Inactivation Market

13.1. India Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viral Inactivation Market

14.1. Japan Viral Inactivation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viral Inactivation Market

15.1. Australia Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viral Inactivation Market

16.1. Indonesia Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viral Inactivation Market

17.1. South Korea Viral Inactivation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viral Inactivation Market

18.1. Taiwan Viral Inactivation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viral Inactivation Market

19.1. South East Asia Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viral Inactivation Market

20.1. Western Europe Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viral Inactivation Market

21.1. UK Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viral Inactivation Market

22.1. Germany Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viral Inactivation Market

23.1. France Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viral Inactivation Market

24.1. Italy Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viral Inactivation Market

25.1. Spain Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viral Inactivation Market

26.1. Eastern Europe Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viral Inactivation Market

27.1. Russia Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viral Inactivation Market

28.1. North America Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viral Inactivation Market

29.1. USA Viral Inactivation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viral Inactivation Market

30.1. Canada Viral Inactivation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viral Inactivation Market

31.1. South America Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viral Inactivation Market

32.1. Brazil Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viral Inactivation Market

33.1. Middle East Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viral Inactivation Market

34.1. Africa Viral Inactivation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Viral Inactivation Market, Segmentation By Product, Segmentation By Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viral Inactivation Market Regulatory and Investment Landscape

36. Viral Inactivation Market Competitive Landscape And Company Profiles

36.1. Viral Inactivation Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Viral Inactivation Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Viral Inactivation Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Texcell SA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. SGS SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Viral Inactivation Market Other Major And Innovative Companies

Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc.

38. Global Viral Inactivation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Viral Inactivation Market

40. Viral Inactivation Market High Potential Countries, Segments and Strategies

40.1 Viral Inactivation Market In 2030 - Countries Offering Most New Opportunities

40.2 Viral Inactivation Market In 2030 - Segments Offering Most New Opportunities

40.3 Viral Inactivation Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Viral Inactivation Market, Overview Of Key Products - Product Examples
  • Table 2: Global Viral Inactivation Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Viral Inactivation Market, Supply Chain Analysis
  • Table 4: Global Viral Inactivation Market, Major Raw Material Providers
  • Table 5: Global Viral Inactivation Market, Major Resource Providers
  • Table 6: Global Viral Inactivation Market, Major Manufacturers (Suppliers)
  • Table 7: Global Viral Inactivation Market, Major Distributors And Channel Partners
  • Table 8: Global Viral Inactivation Market, Key Technologies & Future Trends
  • Table 9: Global Viral Inactivation Market, Major Trends
  • Table 10: Global Viral Inactivation Market, Major End Users
  • Table 11: Global Viral Inactivation Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Viral Inactivation Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Viral Inactivation Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Viral Inactivation Market - TAM, US$ Billion, 2025
  • Table 15: Global Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Viral Inactivation Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Viral Inactivation Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Viral Inactivation Market, Sub-Segmentation Of Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Viral Inactivation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Viral Inactivation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Viral Inactivation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Viral Inactivation Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Viral Inactivation Market - Company Scoring Matrix
  • Table 98: Merck & Co. Inc. Financial Performance
  • Table 99: Sartorius AG Financial Performance
  • Table 100: Texcell SA Financial Performance
  • Table 101: SGS SA Financial Performance
  • Table 102: Charles River Laboratories Inc. Financial Performance
  • Table 103: Global Viral Inactivation Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Viral Inactivation Market, Competitive Dashboard
  • Table 105: Global Viral Inactivation Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Viral Inactivation Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 107: Global, Viral Inactivation Market Size Gain ($ Billion), Segmentation By Method, 2025 – 2030
  • Table 108: Global, Viral Inactivation Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Viral Inactivation Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Viral Inactivation Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Viral Inactivation Market, Supply Chain Analysis
  • Figure 4: Global Viral Inactivation Market, Major Raw Material Providers
  • Figure 5: Global Viral Inactivation Market, Major Resource Providers
  • Figure 6: Global Viral Inactivation Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Viral Inactivation Market, Major Distributors And Channel Partners
  • Figure 8: Global Viral Inactivation Market, Key Technologies & Future Trends
  • Figure 9: Global Viral Inactivation Market, Major Trends
  • Figure 10: Global Viral Inactivation Market, Major End Users
  • Figure 11: Global Viral Inactivation Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Viral Inactivation Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Viral Inactivation Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Viral Inactivation Market - TAM, US$ Billion, 2025
  • Figure 15: Global Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Viral Inactivation Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Viral Inactivation Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Viral Inactivation Market, Sub-Segmentation Of Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Viral Inactivation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Viral Inactivation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Viral Inactivation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Viral Inactivation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Viral Inactivation Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Viral Inactivation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Viral Inactivation Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Viral Inactivation Market - Company Scoring Matrix
  • Figure 98: Merck & Co. Inc. Financial Performance
  • Figure 99: Sartorius AG Financial Performance
  • Figure 100: Texcell SA Financial Performance
  • Figure 101: SGS SA Financial Performance
  • Figure 102: Charles River Laboratories Inc. Financial Performance
  • Figure 103: Global Viral Inactivation Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Viral Inactivation Market, Competitive Dashboard
  • Figure 105: Global Viral Inactivation Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Viral Inactivation Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 107: Global, Viral Inactivation Market Size Gain ($ Billion), Segmentation By Method, 2025 – 2030
  • Figure 108: Global, Viral Inactivation Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Frequently Asked Questions

The Viral Inactivation market was valued at $5.47 billion in 2025, increased to $6.05 billion in 2026, and is projected to reach $9.17 billion by 2030.

The global Viral Inactivation market is expected to grow at a CAGR of 10.9% from 2026 to 2035 to reach $9.17 billion by 2035.

Some Key Players in the Viral Inactivation market Include, Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Pall Corporation And Eurofins Scientific, Cytiva, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG .

Major trend in this market includes: Advancing Safety And Efficiency With Next-Generation Viral-Clearance Solutions. For further insights on this market. request a sample here

North America was the largest region in the viral inactivation market in 2025. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts